Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GDNF gene therapy for Parkinson's disease

Feb. 17, 1997

Third launch for Zyprexa

Feb. 17, 1997

Nymox drug candidate for AD to enter phase I

Feb. 14, 1997

HMR synthesizes potent AChE inhibitor

Feb. 14, 1997

Paroxetine inhibits NOS

Feb. 13, 1997

Valproate efficacy in major depressive disorder

Feb. 13, 1997

Encouraging phase IIb results for antiparkinsonian patch

Feb. 13, 1997

Alza obtains rights to opioid analgesic and licenses the product to Knoll

Feb. 13, 1997

Potential cognition-enhancing agent described by Rotta

Feb. 12, 1997

Servier describes 5-HT3 agonist with additionial antagonist-like properties

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...